Hip Replacement Versions and Their Clinical Importance
Primary Prosthesis Types
The two main bearing surface combinations for total hip replacement are cemented versus uncemented fixation, and ceramic-on-ceramic (COC) versus ceramic-on-polyethylene (COP) articulations, with choice primarily determined by patient age and bone quality rather than superior clinical outcomes. 1
Cemented vs. Uncemented Prostheses
In younger patients, uncemented prostheses are generally preferred because later revisions are technically easier due to preserved bone structure, though the difference in long-term durability between cemented and uncemented hip prostheses is not large 1
Cemented femoral stems should be used in patients with compromised bone quality, particularly in elderly patients with fragility fractures 2
The choice between cemented and uncemented fixation has no comparative studies specifically in ankylosing spondylitis patients, despite their unique bone quality considerations 1
Bearing Surface Options
Ceramic-on-ceramic (COC) articulations demonstrate superior wear resistance compared to ceramic-on-polyethylene (COP), but this theoretical advantage does not translate into clinically meaningful differences in hip function, loosening rates, dislocation rates, revision rates, or osteolysis rates 3, 4
COC bearings have significantly higher rates of prosthesis fracture and squeaking sounds compared to COP bearings, which represents a quality-of-life consideration 3
COP bearings show higher wear rates than COC, but polyethylene wear debris remains a concern for long-term osteolysis and aseptic loosening 3, 4
At 2-year follow-up in a randomized trial of 444 patients, clinical and radiographic outcomes between COC and COP groups were comparable, with no spontaneous ceramic bearing failures observed 4
Clinical Outcomes and Importance
Pain Relief and Function
Total hip replacement achieves 43-84% pain-free outcomes at 9.4-year follow-up, with mean Harris hip score improvements ranging from 36% to 46% from baseline 5, 2
Despite high overall satisfaction, 27% of patients experience some discomfort and up to 6% experience severe chronic pain after THR 6
The strength of recommendation for total hip replacement is 86% based on expert consensus, despite only category III evidence for efficacy, reflecting the overwhelming clinical experience supporting this intervention 1
Revision Rates
Revision rates are acceptable at 0.18-2.04 per 100 person-years when adjusted for age, sex, and type of hip arthritis 5, 2
Age and sex predict revision rates in total hip arthroplasty, but revision rates in ankylosing spondylitis patients are not unduly high 1
Critical Surgical Considerations
Patient Selection
Total hip replacement should be considered in patients with refractory pain or disability and radiographic evidence of structural damage, independent of age 1
For displaced femoral neck fractures in healthy, active, and independent older individuals without cognitive dysfunction, total hip replacement is preferred over hemiarthroplasty 1
In frail patients with femoral neck fractures, hemiarthroplasty may be preferred due to shorter operative time and lower dislocation risk, though functional outcomes are less optimal 1
Preoperative Planning
Obtain CT without IV contrast before surgery to assess joint congruence, component positioning requirements, intraarticular fracture fragments, acetabular wall fractures, and bony impingement mechanisms 2
Add MRI without IV contrast if soft tissue pathology assessment is needed, particularly for evaluating abductor tendon integrity and muscle injuries that may compromise stability 2
Perioperative Management
NSAID treatment does not need to be discontinued for total hip arthroplasty surgery, as administration on the evening before surgery does not affect perioperative bleeding or complication rates 1
Heterotopic ossification rates are not increased in ankylosing spondylitis patients, and routine preoperative NSAID prophylaxis is standard practice 1
Multimodal analgesia with preoperative nerve blocks facilitates early mobilization while maintaining hip precautions 2
Common Pitfalls
There is no high-quality randomized controlled trial evidence comparing total hip replacement to non-operative care, as ethical and practical issues prevent blinding of surgical treatments 1
The high-profile failure of metal-on-metal prostheses has exposed shortcomings in the existing regulatory framework for implant approval 7
Current treatments cannot reverse hip osteoarthritis or restore damaged cartilage—they only control symptoms and improve function 5, 2
Joint-preserving procedures (osteotomy, arthroscopic debridement) only redistribute mechanical forces and do not reverse existing damage, making them inappropriate for advanced disease 5, 2